Proton Radiotherapy with Induction Chemotherapy for Locally Advanced Pancreatic Cancer: A Retrospective Analysis of Treatment Strategy and Outcomes [0.03%]
质子放疗联合诱导化疗治疗局部晚期胰腺癌的回顾性分析：治疗策略和预后效果分析
K Terashima,K Ami,D Takahashi et al.
K Terashima et al.
Background and purpose: The optimal sequencing of chemotherapy and proton therapy (PT) for locally advanced pancreatic cancer (LAPC) remains to be elucidated. This study aimed to evaluate the clinical outcomes of PT in re...
Real-World Pattern of Care Analysis of Liver Reirradiation Among European Organisation for Research and Treatment of Cancer Members [0.03%]
欧洲癌症研究与治疗组织成员再肝放疗的实际情况分析
C De la Pinta,T E Kroese,A Cammarota et al.
C De la Pinta et al.
Background and purpose: Liver re-irradiation is an increasingly used treatment for hepatocellular carcinoma (HCC), liver metastases, and intrahepatic cholangiocarcinoma (ICCA). Technological advances now enable precise de...
Lessons in the Importance of Digital Proficiency for Telehealth-Based Interventions in Low- and Middle-Income Nations [0.03%]
低收入和中等收入国家针对基于数字技能的远程医疗干预的重要性的研究教训
S Chakraborty,N Misra,S Banerjee et al.
S Chakraborty et al.
Development of Key Performance Indicators for a National Head and Neck Cancer Audit Feasibility Study [0.03%]
头颈癌国家审计关键绩效指标开发可行性研究
J Song,F Jashek-Ahmed,K Walker et al.
J Song et al.
Aims: To develop key performance indicators (KPIs) for evaluating quality, equity, and outcomes of head and neck cancer (HNC) care. Methods: ...
Survival and Toxicity in Elderly Patients Treated With Chemoradiotherapy for Head and Neck Cancer: A Retrospective Study at a Large Quaternary Centre [0.03%]
头颈癌老年患者综合治疗的疗效和毒性：大型四级中心的回顾性研究
P Sekar,J Goetz,G Ng et al.
P Sekar et al.
Aim: Limited evidence supports the benefit of chemoradiotherapy for locally advanced head and neck cancer (LA-HNSCC) in elderly patients. Further evidence is needed to support the use of combined modality approaches in el...
A Real-World Study: Effect of the Third-Line Therapy of Fruquintinib or Regorafenib Therapy Versus Rechallenge Chemotherapy in Metastatic Colorectal Cancer [0.03%]
真实世界研究：呋喹替尼和瑞戈非尼三线治疗与化疗再挑战治疗转移性结直肠癌的效果比较
X Xu,H Xu,Y Liu et al.
X Xu et al.
Aim: Third-line treatment options for metastatic colorectal cancer (mCRC) remain limited. Chemotherapy rechallenge has shown efficacy in this setting, but direct comparisons with tyrosine kinase inhibitors (TKIs) are lack...